Clinical Trial: Cancer

NCCTG N0392 Cancer Trials Patient Satisfaction Study (PRO00000232)

Full Name

Assessment of patient satisfaction with participation in Phase II/III NCCTG clinical trials

Description

Participants complete baseline survey before beginning treatment on parent protocol. After one cycle (or one month, if cycle is not defined), study team designee administers the Was It Worth It (WIWI) questionnaire. WIWI questionnaire is re-administered at the end of active treatment or at one year, whichever is soonest. Participants have the option to complete questionnaires during the week after the clinical visit, and return them within one week of the visit.

Eligibility

Inclusion Criteria
Inclusion Criteria-including but may not be limited to:
  • Enrollment in an appropriate NCCTG-sponsored clinical trial
  • Ability to complete questionnaire booklets
Doctor(s) Running This Study

Specialties

  • Hematology/Medical Oncology

Area of focus i

  • Melanoma
  • Kidney cancer (renal cancer)
  • Sarcoma

Affiliated with

LVPG Cliniciani

Accepting New Patients